(Q40394117)

20 September 2017

1 reference

title

Treatment of aggressive non-Hodgkin' lymphomas. Lessons from the past 10 years (English)

1 reference

20 September 2017

Treatment of aggressive non-hodgkin's lymphomas: Lessons from the past 10 years (English)

1 reference

10.1002/1097-0142(19941101)74:9+<2657::AID-CNCR2820741812>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(19941101)74:9+%3C2657::AID-CNCR2820741812%3E3.0.CO;2-T

18 May 2024

author name string

R. I. Fisher

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525045

18 May 2024

language of work or name

English

0 references

publication date

1 November 1994

1 reference

full work available at URL

20 September 2017

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819941101%2974%3A9%20%3C2657%3A%3AAID-CNCR2820741812%3E3.0.CO%3B2-T

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525045

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19941101)74:9+%3C2657::AID-CNCR2820741812%3E3.0.CO;2-T

18 May 2024

1 reference

10.1002/1097-0142(19941101)74:9+<2657::AID-CNCR2820741812>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(19941101)74:9+%3C2657::AID-CNCR2820741812%3E3.0.CO;2-T

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19941101)74:9+%3C2657::AID-CNCR2820741812%3E3.0.CO;2-T

18 May 2024

1 reference

10.1002/1097-0142(19941101)74:9+<2657::AID-CNCR2820741812>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(19941101)74:9+%3C2657::AID-CNCR2820741812%3E3.0.CO;2-T

18 May 2024

1 reference

20 September 2017

volume

74

1 reference

20 September 2017

issue

9 Suppl

1 reference

20 September 2017

page(s)

2657-2661

1 reference

Advanced diffuse histiocytic lymphoma, a potentially curable disease

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819941101%2974%3A9%2B%3C2657%3A%3AAID-CNCR2820741812%3E3.0.CO%3B2-T

Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819941101%2974%3A9%2B%3C2657%3A%3AAID-CNCR2820741812%3E3.0.CO%3B2-T

Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819941101%2974%3A9%2B%3C2657%3A%3AAID-CNCR2820741812%3E3.0.CO%3B2-T

Chemotherapy for large-cell lymphoma: optimism and caution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819941101%2974%3A9%2B%3C2657%3A%3AAID-CNCR2820741812%3E3.0.CO%3B2-T

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819941101%2974%3A9%2B%3C2657%3A%3AAID-CNCR2820741812%3E3.0.CO%3B2-T

Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819941101%2974%3A9%2B%3C2657%3A%3AAID-CNCR2820741812%3E3.0.CO%3B2-T

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

21 January 2018

1

1 reference

10.1002/1097-0142(19941101)74:9+<2657::AID-CNCR2820741812>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(19941101)74:9+%3C2657::AID-CNCR2820741812%3E3.0.CO;2-T

Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy

18 May 2024

7

1 reference

10.1002/1097-0142(19941101)74:9+<2657::AID-CNCR2820741812>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(19941101)74:9+%3C2657::AID-CNCR2820741812%3E3.0.CO;2-T

Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD)

18 May 2024

8

1 reference

10.1002/1097-0142(19941101)74:9+<2657::AID-CNCR2820741812>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(19941101)74:9+%3C2657::AID-CNCR2820741812%3E3.0.CO;2-T

Combination Chemotherapy of Advanced Diffuse Histiocytic Lymphoma with the Six-Drug COP-BLAM Regimen

18 May 2024

9

1 reference

10.1002/1097-0142(19941101)74:9+<2657::AID-CNCR2820741812>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(19941101)74:9+%3C2657::AID-CNCR2820741812%3E3.0.CO;2-T

Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial

18 May 2024

10

1 reference

10.1002/1097-0142(19941101)74:9+<2657::AID-CNCR2820741812>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(19941101)74:9+%3C2657::AID-CNCR2820741812%3E3.0.CO;2-T

Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD

18 May 2024

11

1 reference

10.1002/1097-0142(19941101)74:9+<2657::AID-CNCR2820741812>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(19941101)74:9+%3C2657::AID-CNCR2820741812%3E3.0.CO;2-T

MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma

18 May 2024

13

1 reference

10.1002/1097-0142(19941101)74:9+<2657::AID-CNCR2820741812>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(19941101)74:9+%3C2657::AID-CNCR2820741812%3E3.0.CO;2-T

m-BACOD treatment for intermediate- and high-grade malignant lymphomas: a Southwest Oncology Group phase II trial

18 May 2024

14

1 reference

10.1002/1097-0142(19941101)74:9+<2657::AID-CNCR2820741812>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(19941101)74:9+%3C2657::AID-CNCR2820741812%3E3.0.CO;2-T

Unfavorable histologies of non-Hodgkin's lymphoma treated with ProMACE-CytaBOM: a groupwide Southwest Oncology Group study

18 May 2024

15

1 reference

10.1002/1097-0142(19941101)74:9+<2657::AID-CNCR2820741812>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(19941101)74:9+%3C2657::AID-CNCR2820741812%3E3.0.CO;2-T

Combination chemotherapy of intermediate-grade and high-grade non-Hodgkin's lymphoma with MACOP-B: a Southwest Oncology Group study

18 May 2024

16

1 reference

10.1002/1097-0142(19941101)74:9+<2657::AID-CNCR2820741812>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(19941101)74:9+%3C2657::AID-CNCR2820741812%3E3.0.CO;2-T

Pounding in the neck in supraventricular tachycardia

18 May 2024

17

1 reference

10.1002/1097-0142(19941101)74:9+<2657::AID-CNCR2820741812>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(19941101)74:9+%3C2657::AID-CNCR2820741812%3E3.0.CO;2-T

A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study.

18 May 2024

18

1 reference

10.1002/1097-0142(19941101)74:9+<2657::AID-CNCR2820741812>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(19941101)74:9+%3C2657::AID-CNCR2820741812%3E3.0.CO;2-T

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

18 May 2024

24

1 reference

10.1002/1097-0142(19941101)74:9+<2657::AID-CNCR2820741812>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(19941101)74:9+%3C2657::AID-CNCR2820741812%3E3.0.CO;2-T

18 May 2024

Identifiers

10.1002/1097-0142(19941101)74:9+<2657::AID-CNCR2820741812>3.0.CO;2-T

1 reference

20 September 2017

1 reference